| Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [520][521][522] 523 [524][525][526][527] Next Page Last Page Total 15525 items, 25 items/Page Total 621Page Goto
| 2A-2194525 |
3(4'-Methoxyphenyl)-4-phenyl coumarin |
2A-2194525 |
|
0% |
Inquiry |
| 2A-2194526 |
3-(4-Methoxyphenyl)-7-methoxy-4-hydroxy coumarin |
2A-2194526 |
|
0% |
Inquiry |
| 2A-2194527 |
5-Methyl 2 bromo thiozole |
2A-2194527 |
|
0% |
Inquiry |
| 2A-2194528 |
N-acetyl piperzine |
2A-2194528 |
|
0% |
Inquiry |
| 2A-2194529 |
5-Nitro ortho toluene sulfanamide |
2A-2194529 |
|
0% |
Inquiry |
| 2A-2194530 |
N-Larye mono ethanol amine |
2A-2194530 |
|
0% |
Inquiry |
| 2A-2194531 |
Naproxine |
2A-2194531 |
|
0% |
Inquiry |
| 2A-2194532 |
8-Oxo nonanoic acid phenyl-amide |
2A-2194532 |
|
0% |
Inquiry |
| 2A-2194533 |
6-Oxo-N-me-N.A(INT+Find) |
2A-2194533 |
|
0% |
Inquiry |
| 2A-2194534 |
5-OH,6-No2-Nicotinic acid |
2A-2194534 |
|
0% |
Inquiry |
| 2A-2194535 |
P-nitro phonoxy acetic acid |
2A-2194535 |
|
0% |
Inquiry |
| 2A-2194536 |
Pera hydroxy acetamide |
2A-2194536 |
|
0% |
Inquiry |
| 2A-2194540 |
Picrotixin |
2A-2194540 |
|
0% |
Inquiry |
| 2A-2194541 |
Piperdine hydantoin ABP-922 |
2A-2194541 |
|
0% |
Inquiry |
| 2A-2194542 |
Propyl hydroxy benzaldehyde |
2A-2194542 |
|
0% |
Inquiry |
| 2A-2194543 |
Piperlangumine |
2A-2194543 |
|
0% |
Inquiry |
| 2A-2194544 |
Para Hydroxy Aetamide |
2A-2194544 |
|
0% |
Inquiry |
| 2A-2194545 |
Penta acetate glucosamine |
2A-2194545 |
|
0% |
Inquiry |
| 2A-2194546 |
Scopolitine final |
2A-2194546 |
|
0% |
Inquiry |
| 2A-2194547 |
3,4,5-Tri methoxy phenyl acetate |
17742-46-0 |
|
0% |
Inquiry |
| 2A-2194548 |
2',3',6'-Tri hydroxy flavone |
744252-76-4 |
|
0% |
Inquiry |
| 2A-2194549 |
2',4,4'-Tri methoxy tolane |
2A-2194549 |
|
0% |
Inquiry |
| 2A-2194550 |
4,3',5'-Trichloro-2-hydroxy benzophenone |
2A-2194550 |
|
0% |
Inquiry |
| 2A-2194551 |
4,3',5'-Trichloro-2-hydroxy Chalcone |
2A-2194551 |
|
0% |
Inquiry |
| 2A-2194552 |
3',4',5'-Trimethoxy-4-chlorochalcone |
2A-2194552 |
|
0% |
Inquiry |
| |
|
|
|
